製品名:Potassium ((cyclopropylamino)methyl)trifluoroborate

IUPAC Name:potassium [(cyclopropylamino)methyl]trifluoroboranuide

CAS番号:1402345-98-5
分子式:C4H8BF3KN
純度:95%+
カタログ番号:CM208916
分子量:177.02

包装単位 有効在庫 価格(USD) 数量
CM208916-100mg in stock ǧƙ
CM208916-250mg in stock țƀNJ
CM208916-1g in stock ƀŴȁ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1402345-98-5
分子式:C4H8BF3KN
融点:-
SMILESコード:F[B-](F)(CNC1CC1)F.[K+]
密度:
カタログ番号:CM208916
分子量:177.02
沸点:
MDL番号:MFCD18087754
保管方法:

Category Infos

Borates
Borates are classified as critical materials, they are the main source of boron and have a variety of industrial applications. Organic trifluoroborate is stable to heat, air and humidity, and is a very convenient crystalline boric acid compound. Since it has a tetra-coordinated boronic acid structure after the substitution of fluorine, it does not exhibit Lewis acidity and is stable to oxidation conditions. In addition, it can be regarded as the protector of boronic acid and boronic acid ester, which can be converted into each other. The compound can generally exist stably in organic solvents, but will decompose in protic solvents to liberate trivalent boron, so it can be directly used as a substrate for Suzuki coupling. The difference between trifluoroborate and boric acid is that it must exist in a monomeric form, so the equivalent weight can be closely controlled.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.